1-2 of 2
Tony Marchand
Close
Save search
Sort by
Journal Articles

Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France

Open Access
Clinical Trials & Observations
Camille Bigenwald, Damien Roos-Weil, Arnaud Pagès, Zofia Hélias-Rodzewicz, Christiane Copie-Bergman, Marzieh Nashvi, Pierre Khneisser, Marie Parrens, Alexandra Traverse-Glehen, Isabelle Ray-Coquard, Loïc Ysebaert, Tony Marchand, Jérôme Razanamahery, Frédéric Charlotte, Antoine Neel, Gandhi Damaj, Jérémie Dion, Eve-Marie Nazal-Traissac, Stéphanie Tardy, Géraldine Salmeron, Hélène Monjanel, Ahmed Idbaih, Sébastien Héritier, Julien Haroche, Jean Donadieu, Jean-François Emile
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2530–2541.
https://doi.org/10.1182/bloodadvances.2024015208
Published: 2025
Includes: Supplemental data
Journal Articles

Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry

Free
Florence Rabian, David Beauvais, Tony Marchand, Sabine Fürst, Anne Huynh, Eolia Brissot, Sébastien Maury, Ludovic Gabellier, Patrice Chevallier, Michael Loschi, Stéphanie Nguyen, Marie Balsat, Ingrid Lafon, Amandine Fayard, Vincent Camus, Célestine Simand, Niels Moya, Cristina Castilla-Llorente, Magalie Joris, Ana Berceanu, Anne Thiebaut-Bertrand, Véronique Lhéritier, Eve Gehlkopf, Gabrielle Roth-Guépin, Thibaut Leguay, Nicolas Boissel
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5493–5496.
https://doi.org/10.1182/bloodadvances.2024013962
Published: 2024
Includes: Supplemental data